Precision Health Economics

Precision Health Economics (PHE) is a healthcare consulting firm based in Los Angeles, CA. [1] The company was founded in 2005 by three health economists: Dana Goldman and Darius Lakdawalla from the University of Southern California and Tomas Philipson from the University of Chicago.[2]

Achievements

A 2005 paper by PHE - published in Forum for Health Economics and Policy - was the first to demonstrate that manufacturers of effective therapies capture only a small fraction of the societal benefits to be gained from new treatments, while most benefits go directly to patients. In May 2009, PHE presented a study assessing the value of new health technologies to the NICE Kennedy Commission, which provides recommendations for the development of UK reimbursement policy.

References

  1. ↑ http://www.precisionhealtheconomics.com/about-phe
  2. ↑ http://www.precisionhealtheconomics.com/leadership
This article is issued from Wikipedia - version of the 3/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.